Dec 6
2012
First $1B beneficiary awash in red ink
The biotech company the state plans to spend $50 million on to lure to the Buffalo Niagara Medical Campus has lost $112 million the past three years and hasn’t posted an annual profit since 2008. And that’s just the beginning of the financial difficulties confronting Albany Molecular Research, according to a probe by Investigative Post. The company has laid off at least 80 employees since 2010 and shuttered one of its foreign facilities, with plans to close a second operation near Seattle. The Albany-based company’s stock price, meanwhile, sunk from $61.66 in 2001 to $2.26 in December 2011, although the stock[...]